The use of electro-convulsive therapy (ECT) in adolescents is controversial, and few studies have been conducted to assess its efficacy and safety in this population. We report the case of a 19-year-old boy who received two series of ECT, one at 15 and another at 16, for intractable catatonic schizophrenia. Since the age of 17, he has required treatment combining clozapine and maintenance ECT. The course showed a sustained moderate improvement. The treatment permitted the patient to regain some autonomy with moderate adverse effects. ECT remains an uncommon treatment in adolescents, and the current case supports the view that it should not be banned in young people.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00787-008-0724-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Electroconvulsive Therapy-Induced Mania in Bipolar Disorder: A Case Report.
Cureus
December 2024
Psychiatry, Psychiatrisch Ziekenhuis Asster, Sint-Truiden, BEL.
Electroconvulsive therapy (ECT) is widely recognized as a safe and effective intervention for treating severe affective episodes in patients with bipolar disorder. However, it can sometimes precipitate unexpected manic phases in patients treated for a depressive episode, a phenomenon known as ECT-induced mania. While this occurrence is recognized, it remains poorly understood and minimally addressed in the literature.
View Article and Find Full Text PDFMaintenance treatment of catatonia with benzodiazepines: A case series and literature review.
Neuropsychopharmacol Hung
December 2024
College of Medicine, University of Kentucky, Lexington, KY 40506, USA.
Objective: Benzodiazepines, particularly lorazepam, are good options for acute catatonia treatment. Published catatonia literature on benzodiazepine maintenance treatment and benzodiazepine tolerance is limited.
Methods: This is a chart review covering 30 years of clinical experience in the state of Kentucky, (United States of America), where there was no easy access to electroconvulsive therapy.
Practice of Electroconvulsive Therapy in Catalonia in 2022: Results From a Large Cross-Sectional Survey.
J ECT
December 2024
Bipolar and Depressive Disorders Unit, Hospital Clínic de Barcelona, Barcelona, Catalunya, Spain.
Article Synopsis
- The ECT Working Group of the Catalan Society of Psychiatry conducted a survey in 2022 across 20 public hospitals in Catalonia to examine variations in electroconvulsive therapy (ECT) practices.
- The survey included 50 questions covering organization, technique, therapeutic strategies, and resource management, identifying major depression as the primary reason for ECT in 80% of centers.
- Key findings highlighted consistent ECT application rates, a growing complexity in procedures emphasizing quality and safety, and the need for improvements in resource management and team training.
Tardive seizure after electroconvulsive therapy: Prevalence and associated factors.
Encephale
November 2024
University of Tunis El Manar, Faculty of Medicine of Tunis, Department of Psychiatry D, Razi Hospital, Manouba, Tunisia.
Article Synopsis
- Tardive seizures are rare, spontaneous seizures that can occur after electroconvulsive therapy (ECT), potentially leading to severe complications like status epilepticus, and the risk factors and management are not well-defined.
- This study aimed to explore the prevalence of tardive seizures in patients undergoing ECT at Razi Hospital over seven years and to identify factors linked to this occurrence.
- The retrospective analysis included 1,931 ECT sessions from 157 patients, revealing a 4.45% incidence of tardive seizures among patients and a prevalence rate of 0.57% for individual sessions.
Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis.
Schizophr Bull
October 2024
Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, Osaka, 570-8506, Japan.
Article Synopsis
- There is limited evidence on schizophrenia relapse following electroconvulsive therapy (ECT), prompting a systematic review to gather more data on this issue.
- The study analyzed 29 research papers, finding that relapse rates for schizophrenia after acute ECT were 24% at 3 months, increasing to 55% by 24 months.
- Adding maintenance ECT along with antipsychotics significantly lowered the relapse rate to 20% at the 6-month mark, indicating the need for further research to improve treatment strategies post-ECT.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!